Related Experiment Video
Updated: Mar 8, 2026
06:03
Development and Angiographic Use of the Rabbit VX2 Model for Liver Cancer
Published on: January 7, 2019
12.1K
Laparotomy Cryoablation in Rabbit VX2 Pancreatic Carcinoma
Wenlong Zhang1, Huimin Tao, Jianying Zeng
1From the *Department of Hematology and Oncology, China-Japan Union Hospital of Jilin University, Changchun; and †Fuda Cancer Hospital, Jinan University School of Medicine (Guangzhou Fuda Cancer Hospital), and ‡Guangzhou Fuda Cancer Institute, Guangzhou, China.
Pancreas
|January 28, 2017
Summary
Establishing an optimal rabbit model for pancreatic cancer cryoablation, researchers found that matching the iceball size to the tumor size (Treatment B) significantly extended survival in VX2 pancreatic carcinoma models.
Area of Science:
- Oncology
- Surgical Oncology
- Preclinical Research
Background:
- Pancreatic cancer remains a significant health challenge with limited treatment options.
- Cryoablation is a minimally invasive technique explored for tumor destruction.
- Developing effective preclinical models is crucial for advancing pancreatic cancer therapies.
Purpose of the Study:
- To establish a reliable rabbit model for pancreatic carcinoma.
- To determine the optimal cryoablation protocol for pancreatic cancer using laparotomy.
- To evaluate the efficacy of different iceball sizes relative to tumor size in cryoablation.
Main Methods:
- A VX2 tumor xenograft model was established in rabbit pancreases.
- Tumor-bearing rabbits were divided into four groups: control, and three cryoablation treatments with varying iceball-to-tumor size ratios (A: larger, B: equal, C: smaller).
- Survival time and serum neuron-specific enolase (NSE) levels were monitored.
Main Results:
- The VX2 pancreatic carcinoma rabbit model was successfully established, with elevated serum NSE indicating tumor presence.
- Cryoablation groups A and C showed no significant survival benefit compared to controls.
- Treatment B, where the cryoablation iceball diameter matched the tumor size, significantly prolonged survival (P < 0.01).
Conclusions:
- The VX2 pancreatic cancer rabbit model, utilizing NSE as a biomarker, is viable for preclinical studies.
- Matching the iceball diameter to the tumor size (Treatment B) represents a potentially optimal protocol for pancreatic carcinoma cryoablation.
- This optimized cryoablation technique could offer a new treatment option for patients with unresectable pancreatic cancer.
